Series date: 
01/01/2025 - 7:30am to 12/31/2025 - 8:30am

COURSE DIRECTOR
Hatim Hassan, MD, PhD
Ladan Zand, MD

DESCRIPTION
Fellows and consultants collaborate to present an unusual or controversial case seen in clinic or at the hospital.  This case is related to the topic and through interactive discussion, the audience concludes the correct diagnosis or management plan.  At the end of the case presentation, the fellow concludes with a brief, practical review of the topic. 

Live-Streamed; 6 times a year on Friday from 7:30-8:30 a.m.

TARGET AUDIENCE
Allied Health Professionals, Nurses, Nurse Practitioners, Physicians, Physician Assistants, and Resident Fellows. 

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

  • Identify how to apply skills to clinical practice.
  • Define fundamental concepts of acid-base regulations.
  • Identify how to avoid common mistakes and pitfalls.
  • Debate recent literature in the fields of Nephrology and Hypertension.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies:
Hatim Hassan, M.D., Ph.D. - Intellectual Property, Stock Equity, and New Business Venture - Oxalo Therapeutics.
Ladan Zand, MD - Honoraria - Calliditas NA Enterprises, Inc., Calliditas Therapeutics, Otsuka Pharmaceutical Co., Inc., and Travere Therapeutics, Inc., Genentech, Inc., Vera Therapeutics
 
All relevant financial relationships have been mitigated. 

No relevant financial relationship(s) with ineligible companies:
Diane Chicos (Coordinator) 
Kathleen Hegna Zelinske (Coordinator) 
Jacqlyn (Jackie) Oakland (Coordinator) 

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

QUESTIONS?
Contact Kathy Hegna ZelinskeJacqlyn Oakland, or Diane Chicos

*Required Information for Accreditation is posted in Outlook Calendar Invitation.

Where did the idea for the course originate?: 
Minnesota